Intimation for Increase in Authorized capital

Concord Drugs Ltd has informed BSE about an increase in its authorized share capital. Authorized capital is the maximum amount of shares a company is permitted to issue as per its constitutional documents. This change typically requires shareholder approval through an extraordinary general meeting (EGM) or postal ballot. The company has not disclosed the specific quantum of increase or the rationale in this intimation. Such moves are often preparatory steps for future corporate actions like rights issues, bonus issues, or private placements. The current paid-up capital versus the new authorized limit will determine the headroom available for further share issuance.